Immediate Impact
51 standout
Citing Papers
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
2025 Standout
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
2025 Standout
Works of Jun Nakata being referenced
WT1 epitope‑specific IgG and IgM antibodies for immune‑monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine
2022
Syndecan-4 as a Biomarker to Predict Clinical Outcome for Glioblastoma Multiforme Treated with WT1 Peptide Vaccine
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jun Nakata | 175 | 159 | 150 | 37 | 385 | |
| Nicholas A. Zorko | 169 | 101 | 157 | 28 | 451 | |
| Sebastian Klobuch | 187 | 131 | 214 | 35 | 434 | |
| K. P. Schofield | 116 | 118 | 81 | 23 | 444 | |
| Martín Bonamino | 167 | 126 | 222 | 24 | 424 | |
| Valentina Bertaina | 184 | 99 | 108 | 30 | 382 | |
| Heath L. Bradley | 140 | 185 | 161 | 19 | 422 | |
| Fusayuki Omori | 171 | 92 | 111 | 34 | 436 | |
| Andrea N. Marcogliese | 112 | 157 | 184 | 23 | 372 | |
| Enrico Maffini | 122 | 102 | 150 | 35 | 435 | |
| Daisuke Imanishi | 188 | 107 | 76 | 37 | 420 |
All Works
Login with ORCID to disown or claim papers
Loading papers...